Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.84M Sell
7,843
-302
-4% -$103K 1.57% 19
2026
Q1
$2.87M Buy
8,145
+15
+0.2% +$5.35K 1.68% 17
2025
Q4
$2.66M Buy
+8,130
New +$2.58M 1.59% 22

Other funds holding AMGN

Argo Wealth Advisory's AMGN Position: Q2 2026 in Review

Argo Wealth Advisory reduced its Amgen (AMGN) stake by 3.7% in Q2 2026, selling an estimated $103K and leaving 7,843 shares worth $2.84M. The position accounts for 1.57% of the portfolio, ranked #19.

Argo Wealth Advisory first reported a position in AMGN in Q4 2025 and has held it in 3 quarters since. The position peaked at $2.87M in Q1 2026. 3,133 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Argo Wealth Advisory held 7,843 shares of Amgen worth $2.84M as of Q2 2026.
  • Argo Wealth Advisory sold 302 Amgen shares in Q2 2026, an estimated $103K.
  • Amgen made up 1.57% of Argo Wealth Advisory's portfolio in Q2 2026, its #19 holding.
  • Argo Wealth Advisory first reported a position in Amgen in Q4 2025 and has held it in 3 quarters since.
  • Argo Wealth Advisory's Amgen position peaked at $2.87M in Q1 2026.
  • 3,133 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Argo Wealth Advisory's 13F filing for Q2 2026, filed 7 Aug 2026.